• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX SA VIDAS CMV IGG

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX SA VIDAS CMV IGG Back to Search Results
Catalog Number 30204
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 11/24/2016
Event Type  malfunction  
Event Description
A customer in (b)(6) notified biomérieux of discrepant results associated with the vidas® cmv igg.The customer reported that on (b)(6) 2016, they observed a quality control (qc) out of range when using the vidas® cmv igg.Following this, the customer tested a known positive patient serum sample.The result shifted from positive to equivocal.Patient sample: test 1 - result 8ua/ml positive; test 2 - result 5 ua/ml equivocal.An internal biomérieux investigation will be initiated.
 
Manufacturer Narrative
A customer in (b)(6) notified biomérieux of discrepant results associated with vidas® cmv igg.An internal biomérieux investigation was conducted.The analysis of the quality and batch records for vidas® cmv igg lot 1005099130/170705-0 showed no other complaints, issues or nonconformities in association with the lot.A test was conducted for 8 internal samples on vidas® cmv igg lot 1005099130/170705-0.All samples conformed to the expected results and specifications.A review of quality control records on several batches of vidas® cmv igg showed all samples are within the expected ranges, and lot 170705-0 is in the trend as the other lots.The instructions for use (package insert) indicate the following: -it is recommended to confirm equivocal results using a second sample.-the vidas® cmvg assay results should be interpreted taking into account the clinical symptoms and the medical analysis results from other tests (e.G.Detection of anti-cmv igm in case of primary infection).The investigation concluded the vidas® mv igg lot 1005099130/170705-0 performed as intended.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIDAS CMV IGG
Type of Device
VIDAS CMV IGG
Manufacturer (Section D)
BIOMERIEUX SA
chemin de l orme
marcy l etoile, rhone 69280
FR  69280
Manufacturer (Section G)
BIOMERIEUX SA
chemin de l orme
marcy l etoile, rhone 69280
FR   69280
Manufacturer Contact
ellen weltmer
595 anglum road
st. louis, MO 63042
MDR Report Key6180566
MDR Text Key62544572
Report Number3002769706-2016-00520
Device Sequence Number1
Product Code LFZ
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K920661
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 11/24/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/16/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/05/2017
Device Catalogue Number30204
Device Lot Number1005099130
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/24/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-